INTRODUCTION
Ebola virus, a member of the family Filoviridae, is RNA virus and an emerging infectious agent that causes severe and often fatal hemorrhagic fever in humans and nonhuman primates. [2, 3] 
NATURAL HOST
The natural hosts of Ebola virus are the fruit bats of Pteropodidae family. Since India comes under the home range of these bats, there is a potential risk of Indian population being affected with the virus and its disease [4] [ Figure 1 ].
STRUCTURE
It looks like a piece of thread, or filament, that has been curled up a bit. Ebola is an enveloped virus, meaning that it takes part of the host cell's membrane with it when it leaves the cell.
Like all viruses, Ebola is not able to replicate on its own. It requires the help from a host cell [ Figure 2 ].
CELLS SUSCEPTIBLE
Ebola can infect a variety of cell types, including white blood cells, liver cells, and cells of the adrenal glands.
[1]
MODES OF TRANSMISSION

Body fluids containing Ebola virus
Ebola virus is shed in a wide variety of body fluids during the acute phase of illness, including semen, saliva, breast milk, stool, and tears.
Ebola virus transmitted principally by direct physical contact with an ill person or his/her body fluids during the later stages of illness.
SEXUAL TRANSMISSION
Transmission of the Ebola virus from male to female following exposure to infected semen of survivor has been reported in one event and has been suspected in several others. The exact mode of infection (contact and sexual transmission) has yet not been elucidated. 
Symptoms of Ebola
The time interval from infection with Ebola to the onset of symptoms is 2-21 days, although 8-10 days is most common. Signs and symptoms include:
• Fever, headache, joint and muscle aches, weakness • Diarrhea, vomiting, stomach pain, lack of appetite.
Some patients may experience:
• Rash, red eyes, hiccups • Cough, sore throat, chest pain, difficulty breathing, difficulty swallowing • Bleeding inside and outside of the body. 
Laboratory diagnosis
Ebola virus infections can be diagnosed definitively in a laboratory through several types of tests, including:
• Antigen-capture enzyme-linked immunosorbent assay (ELISA) testing • IgM ELISA • PCR • Virus isolation. 
Treatments for Ebola
At the moment, treatment for Ebola is limited to intensive supportive care and includes:
• Balancing the patient's fluids and electrolytes • Maintaining their oxygen status and blood pressure • Treating a patient for any complicating infections. 
Ebola prevention
There is currently no licensed vaccine available for Ebola. Several vaccines are being tested, but at this time, none are available for clinical use.
Preventing transmission is achieved by:
• Ensuring all health-care workers wear protective clothing and follow universal precautions • Implementing infection-control measures, such as complete equipment sterilization and routine use of disinfectant • Isolation of Ebola patients from contact with unprotected individuals.
Thorough sterilization and proper disposal of needles in hospitals are essential in preventing further infection and halting the spread of an outbreak.
THE WHO RECOMMENDATIONS FOR PREVENTION OF SEXUAL TRANSMISSION
1. All Ebola survivors and their sexual partners should receive counseling to ensure safer sexual practices and be provided with condoms when discharged from ETU. Safer sex strategies include postponing sexual debut, nonpenetrative sex, correct and consistent use of male or female condoms, and reducing the number of sexual partners 2. Male Ebola survivors should be offered semen testing at 3 months after onset of disease, and then, for those who test positive, every month thereafter until their semen tests negative for virus twice by RT-PCR, with at least an interval of 1 week between tests 3. Ebola survivors and their sexual partners should either: HIV, other sexually transmitted infections, and unwanted pregnancy 7. All survivors, their partners, and families should be shown respect, dignity, and compassion. [1] Financial support and sponsorship
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